Horan Securities’s BioNTech BNTX Stock Holding History

Horan Securities’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1	Closed	-$109	–	167
2023 Q2	$109	Hold	1	–	–	﹤0.01%	706
2023 Q1	$126	Hold	1	–	–	﹤0.01%	719
2022 Q4	$152	Hold	1	–	–	﹤0.01%	763
2022 Q3	$0	Hold	1	–	–	﹤0.01%	606
2022 Q2	$0	Hold	1	–	–	﹤0.01%	685
2022 Q1	$0	Hold	1	–	–	﹤0.01%	516
2021 Q4	$0	Buy	+1	New	+$274	﹤0.01%	519

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Horan Securities's BNTX Position: Q3 2023 in Review

Horan Securities sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 1 share — an estimated $109 sold.

Horan Securities first reported a position in BNTX in Q4 2021 and held it in 7 quarters. The position peaked at $152 in Q4 2022. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

Horan Securities reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
Horan Securities sold 1 BioNTech share in Q3 2023, an estimated $109.
Horan Securities first reported a position in BioNTech in Q4 2021 and held it in 7 quarters.
Horan Securities's BioNTech position peaked at $152 in Q4 2022.
252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.